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http://dx.doi.org/10.1016/j.jmii.2012Background/Purpose(s): We investigated whether CD4þCD25þFoxp3þ regulatory T cells (Tregs)
are induced in patients suffering from early-stage septic shock and distinguish them from
noninfectious patients with systemic inflammatory response.
Methods: The study included 37 patients with early-stage septic shock, 15 patients with nonin-
fectious systemic inflammatory response syndrome (SIRS), and 24 heath controls. We prospec-
tively assayed the fraction of Tregs expressing high levels of CD25 and forkhead box P3 (Foxp3)
as well as the plasma levels of interferon-g (IFN-g), interleukin-4 (IL-4), and soluble CD25 in all
the subjects studied.
Results: Compared with the control groups, the plasma levels of IFN-g [66.10 (45.23e85.08)
pg/mL vs. 20.97 (17.58e26.21) pg/mL, p < 0.001] and IL-4 [100.69 (77.41e127.68) pg/mL
vs. 70.40 (64.14e80.15) pg/mL, p < 0.001] as well as the IFN-g/IL-4 ratio [0.66 (0.62e0.67)
vs. 0.30 (0.27e0.33), p < 0.001] were significantly elevated in the patients with early-stage
septic shock, but there was no difference between patients with sepsis and patients with SIRS.
We found that the proportion of CD4þCD25þFoxp3þ T cells was significantly increased in the
patients with early-stage septic shock [(66.82  21.79%) vs. (51.79  21.79%) vs.
(56.45  10.68%), p Z 0.003] in comparison with the SIRS and control groups, which could
be differentiated from the patients with SIRS. The plasma levels of soluble CD25 were also
increased, and positively correlated with the proportion of Tregs in patients with early-
stage septic shock (Spearman correlation coefficient Z 0.390, p Z 0.003).of Critical Care Medicine and Respiratory Intensive Care Unit, Ruijin Hospital, Shanghai Jiao Tong
i-Jin Er Road, Shanghai 200025, China.
o.com.cn (H.-P. Qu).
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Increased proportion of CD4þCD25þFoxp3þ Tregs in ICU patients 339Conclusion: Our findings indicate that the proportion of CD4þCD25þFoxp3þ T cells could be an
indicator for the early diagnosis of sepsis. This proportion can also facilitate the evaluation of
the patient’s immune status and guide suitable immunoregulatory therapy.
Copyright ª 2012, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. All rights
reserved.Introduction
Sepsis is a major cause of death in intensive care units
(ICUs), and the hospitalization and mortality rates for
severe sepsis are increasing rapidly.1 It is well known that
sepsis undermines immune homeostasis by inducing an
initial intense systemic inflammatory response that is
rapidly followed by a negative feedback of anti-
inflammatory processes.2,3 The persistence of a marked
compensatory anti-inflammatory response following sepsis
is termed immunoparalysis. Several studies have reported
that this inhibitory response may decrease the resistance of
the host against secondary nosocomial infections, which
negatively affects the patient’s outcome.4 A recent study
showed that patients with severe sepsis suffer from
immunosuppression toward the later stages of the disease.5
However, data from the early stage of the disease remain
unclear.
As an indicator of immunoparalysis, CD4þCD25þFoxp3þ
regulatory T cells (Tregs) play an important role in the
immune response. These cells exert a pronounced anti-
inflammatory effect through contact-mediated direct inhi-
bition of other immune cells and produce high levels of
soluble CD25, interleukin-4 (IL-4), and IL-10.6,7 Tregs can
cause an imbalance of the Th1/Th2 immune response
[interferon-g (IFN-g)/IL-4] and induce CD4þT cells to
differentiate into Th2 cells. Under septic conditions, the
presence of CD4þCD25þFoxp3þ Tregs, which are the natural
Tregs, indicates immunoparalysis.8 It remains unclear as to
whether CD4þCD25þFoxp3þ Tregs are induced in patients
with early-stage septic shock.
In this study, we assayed the proportion of
CD4þCD25þFoxp3þ Tregs and the plasma levels of IFN-g, IL-
4, and soluble CD25 in patients with early-stage septic
shock. We attempted to find new targets to diagnose sepsis
at an early stage and simultaneously evaluate the immune
status of these patients.Materials and methods
Study population
Patients with systemic inflammatory response syndrome
(SIRS) and septic shock included in the study were from the
respiratory ICU, emergency ICU, cardiac surgery ICU, and
neurosurgery ICU of the Shanghai Ruijin Hospital and their
data were collected between February 2009 and February
2010. The control group consisted of age-matched healthy
individuals selected from the Medical Centre of Ruijin
Hospital. Patients with an immune disease or those who
had recently received (within the past 30 days) potentimmunosuppressive agents were excluded. The study
protocol was approved by the Institutional Review Board
and the Hospital Committee on Ethics of Shanghai Jiao Tong
University School of Medicine, and is consistent with the
standards established by the Declaration of Helsinki.
SIRS group
The patients undergoing elective operations within 24 hours
and meeting the diagnostic criteria for SIRS without signs of
infectionwere included. At least twoof the following criteria
must be present to diagnose SIRS: T > 38C or < 36C; heart
rate > 90 beats/minute; respiratory rate > 20 breaths/
minute or PaCO2 < 32 mmHg; white blood cells > 12
or < 4  109/L.9
Sepsis group
The patients in ICU are diagnosed with sepsis if they meet
the SIRS diagnostic criteria and had evidence of infection,
such as positive findings in bacterial cultures of blood or
other body fluids. The patients in early-stage septic shock
are those who were diagnosed with sepsis within 24 hours.
Such patients were also included in this study.
Control group
The control group included age-matched healthy individ-
uals from the Medical Center of Ruijin Hospital.
Study protocol and methods
Peripheral arterial blood from patients with SIRS was
collectedbetween7:00 and8:00 AMwithin 24 hours after their
operation. Blood was collected from patients with septic
shock within 24 hours after the diagnosis. All the samples
were anticoagulated with ethylenediaminetetraacetic acid.
Flow cytometry
Lymphocytes were separated from 2.5 mL of peripheral
arterial blood by gradient centrifugation in a lymphocyte
separation medium within 2 hours after the samples were
harvested. The lymphocytes were counted and the cell
concentrationwas diluted to 1 106/mL. A human regulatory
T-cell staining kit (Human Regulatory T cell Staining Kit,
eBioscience, San Diego, CA, USA) was used, and fluorescein
isothiocyanateeconjugated CD4 antibody, APC-CD25 anti-
body, and PE-Foxp3 antibody (SantaCruz Biotechnology, Inc.,
Santa Cruz, CA, USA) were separately added to the diluted
lymphocytes. The fluorescence intensity of the cell-surface
antibodies was measured by flow cytometry (FACSCalibur,
BD Biosciences, San Jose, CA, USA), while blank controls and
isotype controlswereused to eliminate autofluorescence and
nonspecific fluorescence. The fluorescence intensity was
portrayed as a scattered two-dimensional dot plot,whichwas
340 F.-Y. Leng et al.stored in the computer. The CD4þCD25þFoxp3þ T-cell ratio
was analyzed using CellQuest software (CD4þCD25þFoxp3þ
T cells % Z CD4þCD25þFoxp3þ T cells/CD4þCD25þ
T cells  100%).
Enzyme-linked immunosorbent assay
Human IL-4 Quantikine HS (R&D Systems, Inc., Minneapolis,
MN, USA), human IFN-g Quantikine Pharmpak (R&D
Systems, Inc., Minneapolis, MN, USA), and human IL-2sRa
Quantikine ELISA kits (R&D Systems, Inc., Minneapolis, MN,
USA), were used to determine the plasma levels of IL-2sRa,
IFN-g, and IL-4, respectively.
Statistical analysis
SPSS version 17.0 (SPSS Inc., Chicago, IL, USA) for Windows
was used for statistical analyses and a two-sided p < 0.05
was considered statistically significant. The Kolmogor-
oveSmirnov test was used to check for normal distribution.
Comparisons between patients with sepsis, patients with
SIRS, and/or healthy volunteers were performed using
Student t test as normally distributed values, Man-
neWhitney U test, and KruskaleWallis test when indicated.
Data are expressed as mean  standard deviation or
median  interquartile range when appropriate. Spearman
rank correlation test was used to test relationship between
two variables.Results
General information
The age factor was not significantly different among
patients in the sepsis group (61.67  11.87) years, the SIRSTable 1 Characteristics of the septic, SIRS, and control groups
Characteristics Control (n Z 24)
Age (years) 56.54  6.37
Gender: female/male 10/14
Diagnosis
Pneumonia e
Pancreatitis e
Others e
Microbiological diagnosis
Acinetobacter baumannii e
Pseudomonas aeruginosa e
Staphylococcus aureus e
Klebsiella pneumoniae e
Escherichia coli e
Enterococcus faecalis e
Hemolytic staphylococcus e
Surgical operation
Cardiac valve replacement e
CABG e
Cardiac tumor resection e
Subtotal resection of thyroid e
CABG Z coronary artery bypass graft surgery; SIRS Z systemic inflamgroup (67.06  12.57) years, and the control group
(56.54  6.37) years. There were 15 cases in the SIRS group
(8 men and 7 women), including 7 cases with cardiac valve
replacement, 6 cases with coronary artery bypass graft, 1
case with cardiac tumor resection, and 1 case with subtotal
resection of thyroid. There were 37 patients (26 men and 11
women) in the sepsis group, including 28 cases of pneu-
monia in which the primary pathogens were Gram-negative
bacterium. A total of 24 age-matched healthy individuals,
including 14 men and 10 women, were included as the
control group. No significant difference was found among
groups with respect to gender composition. All clinical data
from the patients in the sepsis group, the SIRS group, and
the control group are shown in Table 1.
The IFN-g and IL-4 levels are not significantly
different between early-stage sepsis and SIRS
The plasma levels of IFN-g and IL-4 were measured as
indicators of Th1 and Th2 cellular activity, which is regu-
lated by Tregs. The IFN-g and IL-4 levels in the plasma from
the sepsis group were significantly higher than those in the
control group: IFN-g, 66.10 (45.23e85.08) pg/mLversus
20.97 (17.58e26.21) pg/mL, p < 0.001; IL-4, 100.69
(77.41e127.68) pg/mLversus 70.40 (64.14e80.15) pg/mL,
p < 0.001. Compared with the healthy control group, the
levels of these two cytokines in the SIRS group were also
significantly higher: IFN-g, 66.92 (61.20e79.23) pg/mLver-
sus 20.97 (17.58e26.21) pg/mL, p < 0.001; IL-4, 101.81
(94.04e118.68) pg/mLversus 70.40 (64.14e80.15)pg/mL,
p < 0.001. However, there was no significant difference
between the sepsis group and the SIRS group. We also
calculated the IFN-g/IL-4 ratio in which significant differ-
ences between the sepsis group and the control group [0.66
(0.62e0.67) vs. 0.30 (0.27e0.33), p < 0.001] as well asSIRS (n Z 15) Sepsis (n Z 37) p
67.06  12.57 61.67  11.87 0.02
7/8 11/26 0.04
e 28
e 6
e 3
e 13
e 7
e 5
e 5
e 5
e 1
e 1
7 e
6 e
1 e
1 e
matory response syndrome.
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However, there was no significant difference between the
sepsis group and the SIRS group. All statistical data are
shown in Table 2.
The fraction of CD4DCD25DFoxp3D T cells was
significantly elevated at an early stage in patients
with septic shock
We assessed the expression of CD4 and CD25, which are the
characteristic surface markers of Tregs, and found it to be
1.75% (0.59e2.24%) in the sepsis group, 1.08% (0.63e1.90%)
in the SIRS group, and 1.07% (0.80e1.43%) in the control
group (Fig. 1). Although the proportion of CD4 and CD25 was
higher in the sepsis group than in the control and SIRS
groups, the difference was not statistical significant.
However, after the proportion of CD4þCD25þFoxp3þT cells
in CD4þCD25þ T cells was determined using flow cytometry,
the percentage of CD4þCD25þFoxp3þ T cells (Tregs) in
CD4þCD25þ T cells was evaluated. We found that there was
a significant increase in the percentage of Tregs in the
sepsis group [74.40% (53.05e84.68%) vs. 51.76%
(28.46e64.88%) vs. 60.45% (33.24e64.28%), p Z 0.003] in
comparison with the other two groups (data shown in
Fig. 2). No significant difference in the percentage of Tregs
was found between the SIRS group and the control group.
The plasma levels of soluble CD25 were
significantly increased in patients with early-stage
septic shocks
The plasma levels of soluble CD25 (IL-2sRa) were deter-
mined to investigate whether the increase in IL-2sRa in the
plasma of the sepsis group was accompanied by an increase
of CD4þCD25þFoxp3þ Tregs. The plasma level of CD25 in
the sepsis group was significantly higher than that in the
SIRS group and the control group [408.76 (259.85e548.00)
pg/mLvs. 345.94 (243.09e520.77) pg/mLvs. 140.33
(110.56e176.12) pg/mL, p < 0.001]. There was also
a significant difference between the SIRS group and the
control group (Fig. 3A).
Positive correlation between soluble CD25 and
Tregs
We also found that the levels of CD25 cells in the plasma
and the proportion of CD4þCD25þFoxp3þT cells in
CD4þCD25þ T cells were significantly and positivelyTable 2 Levels of IFN-g and IL-4 in the septic, SIRS, and contro
Factor Normal S
IFN-ga (pg/mL) 20.97 (17.58e26.21)
IL-4a (pg/mL) 70.40 (64.14e80.15) 1
IFN-g/IL-4 0.30 (0.27e0.33)
SIRS versus normal: *p < 0.001; sepsis versus normal: **p < 0.001.
IFN Z interferon; IL Z interleukin; SIRS Z systemic inflammatory re
a Values are expressed as median (interquartile range).correlated (Fig. 3B; Spearman correlation
coefficient Z 0.390, p Z 0.003).Discussion
Our study showed that IFN-g and IL-4 levels were highly
increased in patients with early-stage septic shock when
compared with the control, which suggests that the activity
of Th1 and Th2 cells has increased. Although IL-4 was
higher, IFN-g/IL-4 ratio was still elevated. Therefore,
patients who are at the early stage of the sepsis have
increased levels of protective Th1 immunity, which was
similar to the result of a study involving mice with early-
stage septic shock.10 A previous study showed that Tregs
mediated the Th2 predominance in the later stage of the
sepsis.11 Our results suggested IL-4 levels were increased
not only in the later stage of the sepsis but also in the early
stage. So both pro- and anti-inflammatory responses were
activated in patients with early-stage septic shock. The
increased IFN-g/IL-4 ratio suggests that the Th1 and Th2
immune responses are imbalanced. However, in early
stages, the change in the inflammatory cytokines cannot
differentiate sepsis from SIRS.
The principal finding of our study is that that the
patients in early sepsis have a significant increase in the
proportion of Tregs in their peripheral blood, as previously
demonstrated in severe intra-abdominal infections.10
Although Tregs comprise only a small fraction of the T-
lymphocyte population in the immune system, they appear
to potently regulate the activation of other cells in the
immune system, making them an important participant in
the inhibition of the immune response during sepsis. The
patients with septic shock may be benefitted from the
limitation of exacerbated infection-induced pathology, yet
it increases the risk of secondary infection.
We found that the proportion of Tregs in early sepsis is
much higher than that in control and SIRS groups, whereas
no significant difference was found between the SIRS and
control groups. Previous studies also found the same
results, but the correlation between the proportion of Tregs
and the severity of sepsis in patients remains unclear.8,12 It
is suggested that the proportion of Tregs may distinguish
early-stage sepsis from SIRS. Thus, it may be possible for
patients with septic shock to receive more suitable immune
regulation treatment at an earlier time, and the manipu-
lation of Treg cells may offer an innovative therapy for
patients with septic shock. However, further study is
required to understand the conditions under which such
a therapy may be effective.l groups
IRS Sepsis
66.92 (61.20e79.23)* 66.10 (45.23e85.08)**
01.81 (94.04e118.68)* 100.69 (77.41e127.68)**
0.66 (0.65e0.67)* 0.66 (0.62e0.67)**
sponse syndrome.
Figure 1. The fraction of CD4þCD25þ T cells among CD4þ T cells in 37 patients with septic shock [1.75% (0.59e2.24%)], 15
patients with SIRS [1.08% (0.63e1.90%)], and 24 healthy individuals [1.07% (0.80e1.43%)] was detected by flow cytometry. Using
KruskaleWallis test, the overall difference of CD4þCD25þFoxp3þ T cells (regulatory T cells) among CD4þCD25þ T cells in the three
groups found not to be statistically significant. CD4þCD25þ T cells are in the R frame. FITC Z fluorescein isothiocyanate;
SIRS Z systemic inflammatory response syndrome.
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Gram negative. It is unknown whether the type of bacteria
plays a role in the regulation of Tregs in patients with septic
shock. Cook et al found that various Toll-like receptors are
expressed on the surface of Tregs, including lipopolysac-
charide (LPS) receptors such as TLR4.13 It was previously
shown in vivo and in vitro that stimulation with LPS
increased the surface markers for Tregs, which indicatesFigure 2. The fraction of CD4þCD25þFoxp3þ T cells among CD4þC
15 patients with SIRS (51.79  21.79%), and 24 healthy individuals
peak represents the fraction of CD4þCD25þFoxp3þ T cells among th
T cells among CD4þCD25þ T cells is increased in patients with septic
SIRS (SIRS vs. sepsis: *p < 0.05; sepsis vs. normal: **p < 0.05). SIRSthe proliferation and inhibition of apoptosis of these
cells.14
CD25 could be produced by activated Tregs,15 and
CD4þCD25þ T cells can express CD25 using certain enzymes
(e.g., bromelain).16 We found that the CD25 levels in
plasma were increased, as described in a previous study.17
We also found that the plasma levels of CD25 were signifi-
cantly and positively correlated with the proportion ofD25þ T cells in 37 patients with septic shock (66.82  21.79%),
(56.45  10.68%) was detected by flow cytometry. (A) The M2
e CD4þCD25þ T cells. (B) The ratio of forkhead box P3 (Foxp3þ)
shock in comparison with healthy individuals and patients with
Z systemic inflammatory response syndrome.
Figure 3. (A) The plasma levels of soluble CD25 (IL-2sRa) were detected by enzyme-linked immunosorbent assay. Differences
among the three groups were evaluated using a nonparametric KruskaleWallis test. Differences between two groups were eval-
uated using ManneWhitney U test (SIRS vs. normal: *p < 0.001; sepsis vs. normal: **p < 0.001). (B) The level of IL-2sRa (pg/mL) in
plasma and the ratio of CD4þCD25þFoxp3þ regulatory T cells to CD4þCD25þ T cells showed a significantly positive correlation
(Spearman correlation coefficient Z 0.390, p Z 0.003). SIRS Z systemic inflammatory response syndrome.
Increased proportion of CD4þCD25þFoxp3þ Tregs in ICU patients 343Tregs. Thus, the plasma level of CD25 may reflect the
presence of Tregs, suggesting that CD25 may be a conve-
nient marker for the diagnosis of septic shock in patients.
In conclusion, the results of our study indicate that the
proportion of CD4þCD25þFoxp3þ T cells can be helpful in
the early diagnosis of sepsis. The presence of Tregs reflects
the status of immune-suppression in patients with septic
shock. Therefore, determining the proportion of
CD4þCD25þFoxp3þ T cells may allow patients to receive
suitable immune-regulation treatment at an early stage.
Tregs may also offer an innovative therapy for septic
patients in the future.
Limitations
First, the number of the subjects enrolled in this study is
not adequate, especially the patients with SIRS, which may
bias the analysis. Second, the cause of septic shock in our
patients is only due to bacterial infection and thus other
infections such as fungi- or virus-induced sepsis were not
explored. Third, although we tried to find out whether the
sepsis occurred within 24 hours, we could not ensure that
all the patients were really in this stage of the disease.
Finally, the lack of function assay was another limitation of
this study.Acknowledgments
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